Literature DB >> 1660289

Dominance of HTLV type I-specific antibody responsiveness in Old World monkeys.

D L Rudolph, S S Keesling, N Lerche, J A Yee, R Lal.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1660289     DOI： 10.1089/aid.1991.7.721

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  6 in total

1.  Simultaneous detection of antibodies to six nonhuman-primate viruses by multiplex microbead immunoassay.

Authors:  Imran H Khan; Sara Mendoza; Joann Yee; Matthew Deane; Kodumudi Venkateswaran; Shan S Zhou; Peter A Barry; Nicholas W Lerche; Paul A Luciw
Journal:  Clin Vaccine Immunol       Date:  2006-01

Review 2.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

3.  Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys.

Authors:  Y M Chen; Y J Jang; P J Kanki; Q C Yu; J J Wang; R J Montali; K P Samuel; T S Papas
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

4.  Serologic confirmation of simian T-lymphotropic virus type I infection by using immunoassays developed for human T-lymphotropic virus antibody detection.

Authors:  D L Rudolph; J Yee; J Mone; S K Foung; J J Lipka; G R Reyes; K Hadlock; L Chan; F Villinger; M D Lairmore
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

5.  Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes.

Authors:  W M Switzer; D Pieniazek; P Swanson; H H Samdal; V Soriano; R F Khabbaz; J E Kaplan; R B Lal; W Heneine
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Immune recognition of genetically diverse simian T-cell lymphotropic virus type I isolates.

Authors:  A Lazo; R T Bailer; J R Blakeslee; R Yanagihara; V C Stevens; L Kramer; M D Lairmore
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.